Cargando…
A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine
OBJECTIVE: Vestibular paroxysmia (VP) is characterized by short, often oligosymptomatic attacks of vertigo which occur spontaneously or are sometimes provoked by turning the head. Despite the description of the disease almost 40 years ago (first termed “disabling positional vertigo”), no controlled...
Autores principales: | Bayer, Otmar, Brémová, Tatiana, Strupp, Michael, Hüfner, Katharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808055/ https://www.ncbi.nlm.nih.gov/pubmed/29204964 http://dx.doi.org/10.1007/s00415-017-8682-x |
Ejemplares similares
-
Randomized trial of betahistine mesilate tablets as augmentation for oxcarbazepine and carbamazepine in treating vestibular paroxysmia
por: Xue, Hui, et al.
Publicado: (2018) -
Vestibular paroxysmia: Diagnostic criteria
por: Strupp, Michael, et al.
Publicado: (2017) -
Vestibular paroxysmia: a treatable neurovascular cross-compression syndrome
por: Brandt, Thomas, et al.
Publicado: (2016) -
Vestibular paroxysmia in vestibular neuritis: A case report
por: Ori, Michele, et al.
Publicado: (2018) -
Hyperventilation-Triggered Vertigo and Nystagmus in Vestibular Paroxysmia
por: Lee, Suk-Min, et al.
Publicado: (2020)